| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/25/1999 | CA2301796A1 70 human secreted proteins |
| 02/25/1999 | CA2301687A1 Phenethylamine derivatives |
| 02/25/1999 | CA2301295A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 02/25/1999 | CA2301169A1 Porcine mhc class i genes and uses thereof |
| 02/25/1999 | CA2301154A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses |
| 02/25/1999 | CA2301142A1 Fluorescent amyloid a.beta. peptides and uses thereof |
| 02/25/1999 | CA2301138A1 High affinity immunoglobulin e receptor-like protein |
| 02/25/1999 | CA2301043A1 Testis-specific transcription factor zgcl-1 |
| 02/25/1999 | CA2300995A1 Methods for inhibiting detrimental side-effects due to gnrh or gnrh agonist administration |
| 02/25/1999 | CA2300964A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 02/25/1999 | CA2300938A1 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 02/25/1999 | CA2300925A1 Cell chemotactic factor (cctf) originating in mammalian tooth precement or cement, method for purifying the same, and novel connective tissue adhesion promoters containing the same as the active ingredient |
| 02/25/1999 | CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | CA2300903A1 Method of drug selection |
| 02/25/1999 | CA2300878A1 Central nervous system axon regeneration |
| 02/25/1999 | CA2300848A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/25/1999 | CA2300805A1 Polypeptide having a gtpase regulator activity, nucleic acids coding therefor and their use in diagnostics and therapy |
| 02/25/1999 | CA2300801A1 Rab proteins |
| 02/25/1999 | CA2300431A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | CA2300390A1 Human frezzled-like protein |
| 02/25/1999 | CA2300352A1 Novel hiv-specific synthetic oligonucleotides and methods of their use |
| 02/25/1999 | CA2300135A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 02/25/1999 | CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | CA2298867A1 Methods for using granzymes and binding molecules thereof for treating diseases characterized by abnormal apoptosis |
| 02/25/1999 | CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | CA2298855A1 Interleukin-18 binding proteins, their preparation and use |
| 02/25/1999 | CA2298543A1 Loading and release of water-insoluble drugs |
| 02/25/1999 | CA2298540A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 02/25/1999 | CA2297692A1 Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders |
| 02/25/1999 | CA2296322A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient |
| 02/25/1999 | CA2269039A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 02/25/1999 | CA2241430A1 Novel murb |
| 02/25/1999 | CA2241403A1 Murb |
| 02/25/1999 | CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2241390A1 Pigrl-1, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2239260A1 Human disintegrin metalloprotease related to drosophila kuz gene |
| 02/24/1999 | EP0897987A2 Secretion of human protein linked to gamma interferon signal peptide |
| 02/24/1999 | EP0897986A2 Aspartic proteinase 5 (ASP5) |
| 02/24/1999 | EP0897985A2 Consensus phytases |
| 02/24/1999 | EP0897983A2 Antibody against CD40-L |
| 02/24/1999 | EP0897982A2 Sodium bicarbonate co-transporter |
| 02/24/1999 | EP0897981A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897725A2 Therapy for staphylococcus aureus |
| 02/24/1999 | EP0897721A2 Benzo(b)thiophene derivatives for inhibiting detrimental side-effects due to GnRH or GnRH agonist administration |
| 02/24/1999 | EP0897541A1 Identification and isolation of novel polypeptides having ww domains and methods of using same |
| 02/24/1999 | EP0897426A1 Matrix metalloprotease |
| 02/24/1999 | EP0897425A1 Novel trio molecules and uses related thereto |
| 02/24/1999 | EP0897424A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 02/24/1999 | EP0897392A1 Isolation and use of sh3 binding peptides |
| 02/24/1999 | EP0897390A1 Human tumor necrosis factor delta and epsilon |
| 02/24/1999 | EP0740547B1 Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes |
| 02/24/1999 | EP0703900B1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES |
| 02/24/1999 | EP0700440B1 Regulator of contact-mediated hemolysin |
| 02/24/1999 | EP0449968B1 Process for the preparation of human dnase |
| 02/24/1999 | EP0439542B1 Filamentous hemagglutinin of b. pertussis |
| 02/24/1999 | CN1209167A Human chemokine polypeptides |
| 02/24/1999 | CN1209139A Prodrugs of thrombin inhibitors |
| 02/24/1999 | CN1209068A Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
| 02/24/1999 | CN1209066A Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
| 02/24/1999 | CN1209064A Combination therapy for osteoporosis |
| 02/24/1999 | CN1208768A Consensus phytases |
| 02/24/1999 | CN1208731A Recombination human alpha type composite interferon, prepn. method and use therefor |
| 02/23/1999 | US5874585 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| 02/23/1999 | US5874572 Process for preparing cyclosporin A |
| 02/23/1999 | US5874567 Therapeutic oligonucleotides targeting the human MDR1 and MRP genes |
| 02/23/1999 | US5874566 Il-15 triplex oligonucleotides |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874563 Hepatitis G virus and molecular cloning thereof |
| 02/23/1999 | US5874562 Nucleic acid encoding developmentally-regulated endothelial cell locus-1 |
| 02/23/1999 | US5874561 DNA, host cell and vector encoding a protein with cytokine inhibitory activity |
| 02/23/1999 | US5874560 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/23/1999 | US5874557 Enzyme inhibitors which bind to polymerases at ambient temperatures and prevent amplification of nontarget oligonucleotides during polymerase chain reactions; for accurate diagnosis |
| 02/23/1999 | US5874556 Hybrid genes for use in the production of TH -independent cytotoxic T cells |
| 02/23/1999 | US5874546 Genetically engineered protein having specific amino acid sequence |
| 02/23/1999 | US5874543 Platelet factor 4; antiinflammatory agent |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874540 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 02/23/1999 | US5874536 Proteins with Oncostatin M activity and process for their preparation |
| 02/23/1999 | US5874535 Human leptin receptor gene-related protein |
| 02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 02/23/1999 | US5874533 HIV-2 envelope polypeptides |
| 02/23/1999 | US5874531 Polypeptides implicated as self epitope in autoimmune disease pemphigus vulgaris and multiple scelerosis |
| 02/23/1999 | US5874529 Conformationally constrained backbone cyclized peptide analogs |
| 02/23/1999 | US5874528 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2 receptor |
| 02/23/1999 | US5874468 Brain targeted low molecular weight hydrophobic antioxidant compounds |
| 02/23/1999 | US5874424 Inhibitors of interleukin-1β converting enzyme |
| 02/23/1999 | US5874423 Cardiotonic agent |
| 02/23/1999 | US5874419 Compositions and methods for modulating growth of a tissue in a mammal |
| 02/23/1999 | US5874416 Antitumor |
| 02/23/1999 | US5874414 Trans-splicing ribozymes |
| 02/23/1999 | US5874410 Pentapeptide for treatment of skin disorders |
| 02/23/1999 | US5874409 Antiphospholipid analog specifically binds antibodies produced by b cells specific for an antiphospholipid epitope and lacks t cell epitopes; where in the analog is a oligopeptide or polypeptide |
| 02/23/1999 | US5874408 Stabilized albumin-free recombinant factor VII preparation having a low sugar content |
| 02/23/1999 | US5874407 Administering pharmaceutical composition comprising excipient and fusion protein of factor viia active site inhibitor domain, peptide linker domain, and tissue factor domain to inhibit procoagulant activity; cardiovascular disorders |
| 02/23/1999 | US5874406 Synthetic peptide analogs of lung surface protein SP-C |
| 02/23/1999 | US5874405 Heat shock protein peptides that share sequences with cyclic nucleotide phosphodiesterase and methods for modulating autoimmune central nervous system disease |
| 02/23/1999 | US5874404 Immunoglobulin E receptor α-chain inhibits IgE production and secondary allergic responses |
| 02/23/1999 | US5874403 Amino acid conjugates of cyclohexapeptidyl amines |